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  Nine patients with bladder carcinoma were treated by OK－432 local injection． ln 7 out of 9
patients injection was made by transurethral manual and the others were treated by per－cutaneous
injection and one was treated by large－dose intra－tumoral injection of OK－432．
  After local injection of OK－432， endoscopic findings showed white coating of tumor surface and
reduction of tumor size． Histological findings showed necrotic change， exfoliation and degeneration
of tumor cells or small round cells infiltration．
  Immunological parameters such as PPD or PHA skin reactions， peripheral lymphocytes counts
and PHA－induced blastQid transformation of lymphocytes were compared before and after local in－
jection of OK－432． These reactions might be stronger after local injection in many patients．
Especially， PHA skin reaction seemed most useful one as a host resistance among these parameters．
  As adverse reactions of OK－432 local injection， pyrexia and local pain were shown but these re－
actions were ternporary and well controlled by medication．
  We discussed about OK－432 local inj ection against bladder carcinoma as a non－operative treatment．
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Table 1． Cases of OK－432 local injection．






























































÷ Recurrent bladder ca， no surgery
TU ： Transurethral
PC ： Per－cutaneous
case 3 ： Partial cystectomy

























































Case 1， 66y．o． male．
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 Fig． 1 Case 1， small round cells infiltration and tumor cell necrosis （×250）．
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Fig． 2． Case 2， small round cells mfiltration （×100）．
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  Fig． 3． Case 3， small round cells infiltration （×250）．
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Fig． 4． Case 3， exfoliation， necrosis and degeneration of tumor cells （×400）．
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Fig． 5． Case 4， exfoliation of tumor cells， edema of interstitial tissue and small round
  cells infiltration （×400）．
F19．6． Casc 5， necrosls of tumor cells and small round cclls ln丘ltration（×250）・
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Fig． 7． Case 6． cystoscopic findings before OK－432 local injection．
Fig． 8．Case 6， cystoscopic findings
degenerative changes．
after OK－432 local injection， arroNNTs showed
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Fig． 9． Case 7， cystoscopic findings before OK－432 local injection．
Fig． 10． Case 7， cystoscopic findings show bleeding of tumor surfase and degenerative
       changes．
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  Fig． l l． Case 7， severe necrotic changes of tumor cells （×250）．
   Fig． 12． Case 7， small round cells infiltration （×100）．
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Fig． 14． Case 8， metastatic chest tumor and OK－432 injection points are shown．











































































grade III， stage B2であり間質への小円形細胞浸潤
を認めた．現在術後2ヵ月間の経過であるが三三を認
めていない，
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一o It”ig． 15．     30 60Clinical course ef case 9 after re－admission．70 days
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Table 2． lmmunological parameters before and after local injection of OK－432．
PPD skin testPHA sktn testLymphocytesS［




























































































     Bef6re Aft6r
Fig． 16． Lymphocytes ceunt before and after












   o      Before After
Fig． 17． ？PD skin reaction before and after























    Before After
Fig． 18． PHA skin reaction before and after

































     Before After
       （S 1． ： Stimulation hdex）
Fig． 19．． PHA response of lymphocytes before
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Table 3． Effect of OK－432 local injection in
     histological findings．






















｛”n’t／ small round cerls infiltration
Ot edema of interstitial tissue
Cty exfoliation or degeneration of tumor ceils
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